These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22908062)

  • 1. Oncogene-induced senescence in pituitary adenomas and carcinomas.
    Alexandraki KI; Munayem Khan M; Chahal HS; Dalantaeva NS; Trivellin G; Berney DM; Caron P; Popovic V; Pfeifer M; Jordan S; Korbonits M; Grossman AB
    Hormones (Athens); 2012; 11(3):297-307. PubMed ID: 22908062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene-Induced Senescence in Pituitary Adenomas--an Immunohistochemical Study.
    Manojlovic-Gacic E; Skender-Gazibara M; Popovic V; Soldatovic I; Boricic N; Raicevic S; Pekic S; Doknic M; Miljic D; Alafuzoff I; Pontén F; Casar-Borota O
    Endocr Pathol; 2016 Mar; 27(1):1-11. PubMed ID: 26573928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
    Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The release of leptin and its effect on hormone release from human pituitary adenomas.
    Korbonits M; Chitnis MM; Gueorguiev M; Norman D; Rosenfelder N; Suliman M; Jones TH; Noonan K; Fabbri A; Besser GM; Burrin JM; Grossman AB
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):781-9. PubMed ID: 11422113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 Expression in Functioning and Silent ACTH-Producing Adenomas.
    Jin L; Riss D; Ruebel K; Kajita S; Scheithauer BW; Horvath E; Kovacs K; Lloyd RV
    Endocr Pathol; 2005; 16(2):107-14. PubMed ID: 16199895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of an orphan nuclear receptor DAX-1 in human pituitary adenomas.
    Ikuyama S; Mu YM; Ohe K; Nakagaki H; Fukushima T; Takayanagi R; Nawata H
    Clin Endocrinol (Oxf); 1998 May; 48(5):647-54. PubMed ID: 9666878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.
    Kim K; Arai K; Sanno N; Osamura RY; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):759-68. PubMed ID: 11422110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of growth hormone, prolactin and human beta-chorionic gonadotropin mRNA in growth hormone-secreting pituitary adenomas and in prolactin-secreting pituitary adenomas by in situ hybridization using a non-isotopic detection method.
    Tallen G; Fehr S; Saeger W; Uhlig H; Lüdecke DK
    Acta Endocrinol (Copenh); 1993 May; 128(5):411-7. PubMed ID: 8317187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.
    Shimon I; Hinton DR; Weiss MH; Melmed S
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):23-9. PubMed ID: 9509064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome.
    Turner HE; Nagy Z; Gatter KC; Esiri MM; Harris AL; Wass JA
    J Endocrinol; 2000 May; 165(2):475-81. PubMed ID: 10810311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
    Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.
    de Herder WW; Reijs AE; Kwekkeboom DJ; Hofland LJ; Nobels FR; Oei HY; Krenning EP; Lamberts SW
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):755-67. PubMed ID: 9039343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
    Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
    Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and epidemiological characteristics of pituitary tumours in a single centre in Saudi Arabia.
    Hussein SH; Wahedi TS; Johani NA; Hakami YA; Alzahrani K; AlMalki MH
    Hormones (Athens); 2018 Jun; 17(2):261-267. PubMed ID: 29858852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas.
    Sanno N; Sugawara A; Teramoto A; Abe Y; Yen PM; Chin WW; Osamura RY
    Neuroendocrinology; 1997 Apr; 65(4):299-306. PubMed ID: 9143002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
    Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas.
    da Rocha AA; Giorgi RR; de Sa SV; Correa-Giannella ML; Fortes MA; Cavaleiro AM; Machado MC; Cescato VA; Bronstein MD; Giannella-Neto D
    Pituitary; 2006; 9(2):83-92. PubMed ID: 16832584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland.
    Turner HE; Nagy Z; Sullivan N; Esiri MM; Wass JA
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):337-44. PubMed ID: 10971451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.